Q&A: Tackling the rise of fake anti-obesity drugs on the market
Professor Timothy Mackey talks about the recent reports of fraudulent Ozempic pens and the challenges in chasing drug counterfeiters.
Interviews
Q&A: European Pharmaceutical legislation: hindrance or help?
Q&A: UK pharma manufacturing prepares for imminent shake up in 2024
What does CSRD mean for the pharmaceutical industry? ENGIE Impact explains
Q&A: How the Henrietta Lacks settlement challenges biotech’s view on ethics
Q&A: How can the US maintain access to essential drugs?
Q&A: How Big Pharma implements analytics in continuous manufacturing
Q&A: As RSV vaccine approvals loom, regulators need to devise vaccination strategies
